Roche Collaborates with Ibex, Amazon on AI-Enabled Digital Pathology Solutions for Cancer
Roche is collaborating with Ibex and AWS to enable pathology labs to access AI-powered decision support tools to support cancer diagnosis.
Read MorePosted by Andy Lundin | Oct 30, 2023 | Cancer, Digital Pathology |
Roche is collaborating with Ibex and AWS to enable pathology labs to access AI-powered decision support tools to support cancer diagnosis.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Cancer |
Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.
Read MorePosted by Andy Lundin | Oct 16, 2023 | Prostate |
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read MorePosted by Andy Lundin | Oct 11, 2023 | Cancer, Digital Pathology |
CorePlus, a high complexity anatomic pathology laboratory, diagnosed over 10,000 cases using Ibex’s AI-powered cancer diagnostics platform.
Read MorePosted by Andy Lundin | Oct 10, 2023 | Cancer |
The genomic profiling test is approved to identify patients with solid tumors with RET gene fusions who may benefit from Retevmo treatment.
Read More